How can the FDA better support the development of medical technologies, including digital health technologies and diagnostics, for use in non-clinical care settings, such as at home?
From reimbursement challenges, regulatory clarity for low-risk devices, to the rise of AI in home health, here is our perspective on the recent FDA call for comments!
simbex-blog-pdfsimbex-blog-pdf
Recent Posts
